Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB4435/62Aexternal-prioritypatent/GB1036591A/en
Application filed by Wellcome Foundation LtdfiledCriticalWellcome Foundation Ltd
Publication of ES284276A1publicationCriticalpatent/ES284276A1/en
Investigating Or Analysing Biological Materials
(AREA)
Peptides Or Proteins
(AREA)
Abstract
Improvements introduced in the preparation of an immunological reagent for discovering and estimating human chorionic gonadotropin (HCG), characterized in that said reagent comprises red blood cells of mammal sensitized to HCG and a borate buffer. (Machine-translation by Google Translate, not legally binding)
ES284276A1962-02-051963-01-18An immune method for the diagnosis of pregnancy (Machine-translation by Google Translate, not legally binding)
ExpiredES284276A1
(en)
A procedure for preparing a composition of serodiagnosis based on hormone of coronic gonadotropin. (Machine-translation by Google Translate, not legally binding)
A method for producing an immune-indicating system for detecting corionic gonadotropin in a urine sample. (Machine-translation by Google Translate, not legally binding)